WIRE)–At the American Society of Nephrologys Kidney Week 2011, Fresenius Medical Care (NYSE: FMS), the worlds largest
provider of dialysis products and services, announced that it received U.S.
Food and Drug Administration 510 (K) clearance to extend improved touch screen
navigation on its most advanced hemodialysis delivery system, the 2008T.
Effective immediately, all newly produced 2008T machines with Fresenius
Clinical Data Exchange (CDX) will come with this enhancement.
Introduced a year ago at Kidney Week 2010, the 2008T is the
first fully integrated therapy and management information system on the market.
The 2008T combines Fresenius Medical Cares most advanced hemodialysis delivery
system with CDX providing caregivers, for the first time, chair-side access to
the facilitys medical information system and dialysis treatment data.
“With all the key information a medical professional needs,
immediately at hand, they can focus on patient care. The human factors
engineering is an appreciation of how medical professionals actually work in
the clinical setting. The 2008T puts key patient and treatment information more
quickly at the clinicians fingertips,” said Jose A. Diaz-Buxo, MD, FACP, Chief
Medical & Regulatory Affairs Officer, Fresenius Medical Care. “Simplicity,
ease of use and readily available information allows care-givers more time to
focus on the patient.”
About Fresenius Medical Care
Fresenius Medical Care (NYSE: FMS) is the worlds leading company devoted to
patient-oriented renal therapy. Through more than 2,900 clinics in North
America, Europe, Latin America, Asia-Pacific and Africa,
we provide kidney dialysis treatments to approximately 228,000 patients
worldwide. We are also the world’s leading maker of dialysis products such as
hemodialysis machines, dialyzers and related disposable products. Chronic
kidney failure is a condition that affects about 2 million individuals
worldwide. For more information about the companys more than 1,800 U.S. dialysis
facilities, visit www.ultracare-dialysis.com (in English and Spanish). For
more information about Fresenius Medical Care, visit www.fmc-ag.com or www.fmcna.com.